CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Gabriela-Dumitrița Stanciu

OPENALEX: A5008215160↗ORCID: 0000-0003-4440-9628↗

Affiliations

Organizations

Grigore T. Popa University of Medicine and Pharmacyauthorship · RO

Public evidence

6 connected articles

Acute Toxicity of Three Synthetic Cannabinoids: First In Vivo Preclinical Study.2026 · PubMed Central Open Access Evaluation of long-term safety profile of an EU-GMP certified <i>Cannabis sativa</i> L. strain in a naturally aging preclinical model.2025 · Europe PMC Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging.2025 · Europe PMC Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified <i>Cannabis sativa</i> L. in Rodents.2023 · PubMed Central Open Access Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?2021 · Europe PMC Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy.2020 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Gabriela-Dumitrița Stanciu - Medical Cannabis Research Engine